子宫切除术中行输卵管切除术降低上皮性卵巢癌风险的有效性:一项系统综述
该系统综述纳入11项研究,未发现评估子宫切除术同期行输卵管切除术降低上皮性卵巢癌风险的研究;两项回顾性研究报告有指征的输卵管切除较未手术者卵巢癌风险降低,调整风险比分别为0.65(95%CI 0.52-0.81)和调整比值比0.58(95%CI 0.36-0.95),但所有结局证据确定性极低或低,长期内分泌功能影响未知。
要点
- 未发现评估子宫切除术同期输卵管切除降低上皮性卵巢癌风险的研究。
- 有指征输卵管切除较未手术者卵巢癌风险降低,调整HR 0.65(95%CI 0.52-0.81)。
- 所有结局证据确定性极低或低,长期内分泌功能影响未知。
核心结论
- 目前证据不足以说明机会性输卵管切除术可降低上皮性卵巢癌风险,对长期内分泌功能的影响未知,结果异质性和知识空白提示需要前瞻性试验。
研究设计与样本
- 系统综述,检索PubMed、Embase和Cochrane图书馆,纳入原始研究和系统综述,共纳入844篇文献中的11篇,采用GRADE评估证据确定性。
主要发现
- 未发现评估子宫切除术同期输卵管切除降低上皮性卵巢癌风险的研究。
- 两项回顾性研究报告有指征的输卵管切除较未手术者卵巢癌风险降低:调整风险比0.65(95%CI 0.52-0.81)和调整比值比0.58(95%CI 0.36-0.95)。
- 输卵管切除组与未切除组并发症无差异,但报告非系统化。
- 随机或观察性研究中,短期随访的替代结局指标显示卵巢内分泌功能无差异。
- 所有结局的证据确定性为极低或低。
关键数值与推荐
- 有指征输卵管切除较未手术者卵巢癌风险降低:调整HR 0.65(95%CI 0.52-0.81)。
- 有指征输卵管切除较未手术者卵巢癌风险降低:调整OR 0.58(95%CI 0.36-0.95)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未发现评估子宫切除术同期输卵管切除降低上皮性卵巢癌风险的研究。
- 并发症报告非系统化。
- 所有结局的证据确定性为极低或低。
- 结果存在异质性。
- 存在知识空白,需要前瞻性试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been argued that salpingectomy would reduce the risk of epithelial ovarian cancer (EOC), based on the theory of the tube being the site of origin. OBJECTIVES: To conduct a systematic review of 'salpingectomy' associated with ovarian cancer risk and 'salpingectomy with concomitant hysterectomy' on outcomes of complications including endocrine function. SEARCH STRATEGY: A comprehensive search was conducted in PubMed, Embase, and the Cochrane library. SELECTION CRITERIA: Original studies and systematic reviews were eligible. DATA COLLECTION AND ANALYSIS: Each article was quality assessed. Data were extracted and, when possible, pooled in meta-analyses. The certainty of evidence across studies was evaluated using GRADE. MAIN RESULTS: Of 844 articles found, 11 were included. No study evaluated risk reduction for EOC after salpingectomy in conjunction with hysterectomy. Two retrospective studies reported a reduced ovarian cancer risk after indicated salpingectomy, compared with no surgery: adjusted hazard ratio 0.65 (95% confidence interval, 95% CI 0.52-0.81) and adjusted odds ratio 0.58 (95% CI 0.36-0.95). Complications did not differ between groups with or without salpingectomy, but were non-systematically reported. Ovarian endocrine function, measured with surrogate outcomes, did not differ at short-term follow-up in randomised or observational studies. The certainty of evidence was very low or low for all outcomes. CONCLUSIONS: There is currently insufficient evidence to state that opportunistic salpingectomy reduces the risk of EOC. The impact on long-term endocrine function is unknown. The heterogeneity in results and identified knowledge gaps stress the need for a prospective trial. TWEETABLE ABSTRACT: Insufficient evidence for prophylactic removal of the fallopian tubes for risk reduction of ovarian cancer.
引用
- Darelius A, Lycke M, Kindblom JM, et al. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review. BJOG. 2017. PMID: 28190289. doi:10.1111/1471-0528.14601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。